SATURDAY, Nov. 9, 2024 (HealthDay News) — It may seem counter-intuitive, but losing weight without even trying may not be a good thing. “It’s not typical to have a noticeable drop in weight without changing how much you’re eating, being more physically active or trying to lose weight,” said dietitianContinue Reading
THURSDAY, Nov. 7, 2024 (HealthDay News) — The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versions of the active ingredient in those medications have now been linked to at least 100 hospitalizations and 10 deaths. “Honestly, I’m quite alarmedContinue Reading
WEDNESDAY, Nov. 6, 2024 (HealthDay News) — Nearly 16% of American adults — that’s close to 1 in 6 — now has diabetes, according to the latest data from the U.S. Centers for Disease Control and Prevention. Increasing age and widening waistlines greatly increase the odds for the disease, whichContinue Reading
TUESDAY, Nov. 5, 2024 (HealthDay News) — Poorer folks’ access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found. Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers discovered. Under the Medicaid system, individual states areContinue Reading
FRIDAY, Nov. 1, 2024 (HealthDay News) — The GLP-1 drug semaglutide can help obese people manage debilitating knee arthritis, a new trial has found. People who received weekly injections of semaglutide — the active agent in the diabetes drug Ozempic and the weight-loss medication Wegovy — had a nearly 14%Continue Reading
FRIDAY, Nov. 1, 2024 (HealthDay News) — Hillary Fisher thinks receiving weight-loss surgery as a teenager put her on the path to a better life. Fisher is one of 260 teens who participated in a long-term study which recently concluded that weight-loss surgery can bring lasting health benefits for obeseContinue Reading
WEDNESDAY, Oct. 30, 2024 (HealthDay News) — Pancreatic cancer rates are rising in adults younger than 50, but many continue to believe it’s a disease that only affects the elderly, a new survey shows. Folks in that age range also say they wouldn’t be able to identify early signs andContinue Reading
MONDAY, Oct. 28, 2024 (HealthDay News) — The weight-loss drug Ozempic can guard against kidney disease in obese people, a new study shows. Patients taking semaglutide — the active agent in Ozempic and Wegovy — had as much as a 52% reduction in kidney damage, as measured by urine testing,Continue Reading
FRIDAY, Oct. 25, 2024 (HealthDay News) — As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim their waistlines, a new report finds. Prescriptions of this GLP-1 class of diabetes and weight-loss medications more than doubled between 2022 and 2023,Continue Reading
THURSDAY, Oct. 24, 2024 (HealthDay News) — Add Alzheimer’s disease to the list of conditions that might benefit from the revolutionary diabetes drug Ozempic, a new study says. People with type 2 diabetes taking semaglutide appeared to have a significantly lower risk of developing Alzheimer’s compared to patients taking sevenContinue Reading